Protara Therapeutics to Participate in Upcoming Investor Conferences
March 01 2023 - 8:00AM
Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage
company developing transformative therapies for the treatment of
cancer and rare diseases, today announced that management will
participate in the following upcoming investor conferences:
- Cowen 43rd Annual Health Care
Conference. A fireside chat will take place on Wednesday,
March 8, 2023 at 9:50 am ET in Boston, MA.
- Oppenheimer 33rd Annual Healthcare
Conference. A corporate presentation will take place virtually
on Tuesday, March 14, 2023 at 1:20 pm ET.
A live webcast of the events can be accessed by
visiting the Events and Presentations section of the Company’s
website: https://ir.protaratx.com. The webcasts will be archived
for a limited time following the presentation.
About Protara
Therapeutics, Inc.
Protara is committed to advancing transformative
therapies for people with cancer and rare diseases. Protara’s
portfolio includes its lead program, TARA-002, an investigational
cell-based therapy being developed for the treatment of non-muscle
invasive bladder cancer and lymphatic malformations, and IV Choline
Chloride, an investigational phospholipid substrate replacement
therapy for the treatment of intestinal failure-associated liver
disease. For more information, visit www.protaratx.com.
Company Contact:
Justine O'MalleyProtara
TherapeuticsJustine.OMalley@protaratx.com646-817-2836
Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Protara Therapeutics (NASDAQ:TARA)
Historical Stock Chart
From Jul 2023 to Jul 2024